Oral edaravone was approved in 2022 based on bioequivalence and long-term safety studies comparing it with the IV edaravone ...
Gireesh Babu, New Delhi Monday, October 21, 2024, 08:00 Hrs [IST] ...
Objective: To investigate the relative bioavailability and bioequivalence, in fasting and fed conditions, of repeated doses of two omeprazole enteric-coated formulations in healthy volunteers.